Pitch Night: Life Sciences Startups

Pitch Night: Life Sciences Startups
Go back

encourageventures, supported by DKFZ and BioRN, invites you to a special edition of our Pitch Night, dedicated to Life Sciences Startups.

Life sciences is one of the most impactful fields for innovation, with breakthroughs ranging from diagnostics and therapeutics to digital health and biotech solutions. At this Pitch Night, you’ll meet founders who bring science to implementation and create strong investment opportunities.

The evening will start with a short welcome and input from the ecosystem, followed by strong startup pitches. Afterward, you’ll have the chance to join breakout sessions to meet the founders directly, ask questions, and dive deeper into their ideas.

This edition is open to external guests looking to invest in Life Sciences startups.

👉 Register here to join us: Registration Link

We are looking forward to an inspiring evening of innovation, investment, and networking with you!

register now

Our latest News

discover more
Universität Heidelberg with 16 “Highly Cited Researchers”

Universität Heidelberg with 16 “Highly Cited Researchers”

International evaluation names researchers whose publications have been most cited worldwide 16 researchers from Heidelberg University feature on the recently published list of “Highly Cited Researchers”. This international evaluation names researchers whose publications have been cited most frequently worldwide in their respective field or who have an outstanding track-record of publications across several disciplines. The […]

read more
Universität Heidelberg: New DFG Research Unit in Oncology

Universität Heidelberg: New DFG Research Unit in Oncology

GenoMiCC consortium deals with functional genomics and microbiomics in colorectal cancer and is coordinated at the Medical Faculty Mannheim In the latest approval round of the German Research Foundation (DFG), Heidelberg University has been successful with a grant application for a new Research Unit in oncology. The GenoMiCC consortium pursues the goal of identifying new […]

read more
Merck and Promega collaborate on 3D cell technology for drug discovery

Merck and Promega collaborate on 3D cell technology for drug discovery

Full text in German below. Merck und Promega arbeiten gemeinsam an 3D-Zelltechnologie für die Wirkstoffforschung Strategische Partnerschaft bündelt Know-how von Merck im Bereich Organoide mit Promegas Assay-TechnologienForschende erhalten besseren und schnelleren Zugang zu krankheitsrelevanten ZellmodellenStärkt Mercks Position bei zukunftsweisenden Tools und Lösungen auf dem Gebiet der Biologie Darmstadt, Deutschland. (06. November 2025) Merck, ein führendes Wissenschafts- […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp